ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $219,000 | -33.0% | 215,000 | -9.2% | 0.01% | -45.5% |
| Q2 2021 | $327,000 | -3.8% | 236,742 | +18.4% | 0.01% | -15.4% |
| Q1 2021 | $340,000 | +353.3% | 200,000 | +827.0% | 0.01% | +85.7% |
| Q1 2019 | $75,000 | -40.9% | 21,575 | -60.8% | 0.01% | -63.2% |
| Q4 2018 | $127,000 | – | 55,067 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
| SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
| Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
| Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
| Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
| Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
| WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
| CAXTON CORP | 21,870 | $84,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
| Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |